Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $77.40 ($1.9M) on 2019-02-04, disclosed to the SEC on 2019-02-05.
Seasonal sale ($1.9M) by Chief Scientific Officer — this insider has traded GHDX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.70 | 2,192 | $166K | 8.7% |
| 2 | $76.72 | 19,080 | $1.5M | 76.3% |
| 3 | $77.40 | 3,728 | $289K | 15.0% |
| Total | $76.73 avg | 25,000 | $1.9M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $1.3M | — | Filing → |